In a 58-year-old male with hypertrophic obstructive cardiomyopathy, what does systolic hypertension with borderline diastolic pressure and a low‑normal heart rate indicate?

Blood Pressure and Heart Rate Findings in HOCM

This blood pressure of 150/88 mmHg with a heart rate of 61 bpm indicates likely adequate beta-blocker therapy achieving target heart rate control, but reveals concurrent systolic hypertension that requires careful management to avoid worsening left ventricular outflow tract obstruction.

Clinical Interpretation

Heart Rate Assessment

The heart rate of 61 bpm suggests physiologic evidence of beta-blockade, which is the therapeutic goal when treating obstructive HCM 1. Beta-blockers should be titrated until suppression of resting heart rate is demonstrated, and failure of beta-blockade should not be declared until this physiologic evidence is present 1. This heart rate indicates the patient is likely on appropriate beta-blocker dosing for HOCM management.

Blood Pressure Concerns

The systolic blood pressure of 150 mmHg represents stage 2 systolic hypertension that requires attention, but management must be approached cautiously in HOCM:

• Avoid pure vasodilators that can worsen outflow tract obstruction, including:

  • Dihydropyridine calcium channel blockers
  • ACE inhibitors
  • Angiotensin receptor blockers 1

• Preferred agents for concurrent hypertension in symptomatic HOCM:

  • Calcium channel blockers (verapamil or diltiazem) may have a role in managing concomitant hypertension 1
  • These provide both blood pressure control AND negative inotropic effects beneficial for HOCM
  • However, their vasodilating properties can be limiting 1

Critical Management Pitfalls

Do not aggressively treat this blood pressure with standard antihypertensive agents. The 2024 AHA/ACC guidelines explicitly warn that medications used to treat coexisting conditions like hypertension can worsen symptoms related to LVOT obstruction 1.

Key principle: In symptomatic HOCM patients, it may be necessary to uptitrate medications being used for obstructive HCM (like beta-blockers) or consider alternative therapies for the comorbid hypertension rather than adding standard antihypertensives 1.

Hemodynamic Considerations

The borderline diastolic pressure (88 mmHg) combined with controlled heart rate suggests:

• Adequate preload maintenance - critical in HOCM where decreased preload can augment LVOT obstruction 1
• Avoid aggressive diuresis - low-dose diuretics may help congestive symptoms when added to first-line medications, but aggressive diuresis is problematic as it decreases preload and can worsen obstruction 1

The dynamic nature of LVOT obstruction in HOCM means gradients vary significantly with blood pressure, volume status, and heart rate 2. This patient's controlled heart rate helps minimize obstruction, but the elevated systolic pressure requires management that doesn't compromise this benefit.

Recommended Approach

If the patient is asymptomatic: Standard antihypertensive medications can be used cautiously 1

If the patient has symptoms:

1. First, optimize beta-blocker dosing (already appears adequate based on heart rate)
2. Consider adding verapamil or diltiazem for dual benefit of blood pressure control and HOCM management 1
3. Avoid pure vasodilators and high-dose diuretics 1
4. Monitor for symptom changes with any medication adjustments

The combination of adequate heart rate control with persistent systolic hypertension represents a common clinical scenario requiring nuanced management that balances cardiovascular risk reduction with avoiding worsening of LVOT obstruction.